5 A Toolkit for Health Care Professionals Screening for Kidney Disease to Reduce CVD Risk Andrew M. South, MD, MS, is a pediatric nephrologist and director of the Youth-Onset Hypertension Program at Atrium Health Levine Children’s Brenner Children’s Hospital. He is the PI of Collaborative Research (COACH) Catalyst©, whose mission is to better understand the development and progression of kidney disease, hypertension and cardiovascular disease across the life course to support innovative preventive and treatment interventions. Disclosures: Employment: Wake Forest University School of Medicine Independent contractor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant), National Heart, Lung, and Blood Institute (grant) Professional services and activities: Conjupro Biotherapeutics, Inc. Telisa Spikes, PhD, RN, is a tenure-track assistant professor in the Nell Hodgson Woodruff School of Nursing at Emory University. Dr. Spikes’ research interest focuses on chronic stressors derived from the social environment and the impact of their embodiment on physiological aging and cardiovascular disease (CVD) risk in early midlife adult African American women. She has published on psychosocial stressors, hypertension medication adherence and blood pressure reactivity in Black women as well as socioeconomic status and arterial stiffness in Black adults using community-based cohorts and a large epidemiological cohort, Atherosclerosis Risk in Communities (ARIC) study, published in highimpact clinical journals. Disclosures: Employment: Emory University, Nell Hodgson Woodruff School of Nursing Professional services and activities: Nothing to disclose Katherine R. Tuttle, MD, FASN, FACP, FNKF, is executive director for research at Providence Inland Northwest Health and professor of medicine at the University of Washington. Dr. Tuttle’s collective body of work has shaped the “pillars of therapy“ approach to chronic kidney disease and cardiovascular disease in a fundamental manner across the spectrum of scientific discovery, clinical trials and population level implementation. She is chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology and a member of the Cardio-KidneyMetabolic working group for the American Heart Association. Disclosures: Employment: Providence, University of Washington Independent contractor: Travere Therapeutics, Inc. Professional services and activities: AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, ProKidney
RkJQdWJsaXNoZXIy MjI2NjI=